Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab

BACKGROUND: There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFERON-TB Gold (QFT-G)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Chuan-Yu, Chiu, Hsien-Yi, Wang, Ting-Shun, Tsai, Tsen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590912/
https://www.ncbi.nlm.nih.gov/pubmed/28886099
http://dx.doi.org/10.1371/journal.pone.0184178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590912/
https://www.ncbi.nlm.nih.gov/pubmed/28886099
http://dx.doi.org/10.1371/journal.pone.0184178

Ejemplares similares